Xu Pengpeng
Lymphoma and diffuse large B-cell lymphoma
Chief physician
Ruijin Hospital, Shanghai Jiao Tong University School of MedicineA Ruijin haematologist whose original publications address the clinical features, molecular characteristics and prognosis of lymphoma.
Professional background
A 2025 paper in the Journal of Shanghai Jiao Tong University (Medical Science) identifies him as a chief physician at Ruijin haematology and studies diffuse large B-cell lymphoma with adrenal involvement.
This introduction describes published professional work. The hospital confirms the current role, consultation language, appointment location and availability for your enquiry.
This information helps you prepare for a clinical conversation. It does not establish a diagnosis, treatment eligibility or a confirmed booking. A listed hospital or clinician is not a claim of partnership. Seek local urgent care for an emergency.
Sources and references
Related conditions and questions
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma is a type of non-Hodgkin lymphoma that can grow quickly. Accurate pathology and staging help the hematology team plan treatment promptly.
Relapsed or refractory lymphoma
Relapsed lymphoma returns after a response, while refractory disease has not responded adequately to treatment. The exact lymphoma subtype and previous treatment sequence are essential to further assessment.
You don’t have to figure it out alone.
Tell us what you need help with. Your first conversation is free, and there’s no need to have every document ready.